awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q49961144-230064BF-1B4E-4E2E-A21D-E6160ED032BD
Q49961144-230064BF-1B4E-4E2E-A21D-E6160ED032BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49961144-230064BF-1B4E-4E2E-A21D-E6160ED032BD
Targeted therapies for targeted populations: Anti-EGFR treatment for EGFR amplified gastroesophageal adenocarcinoma.
P2860
Q49961144-230064BF-1B4E-4E2E-A21D-E6160ED032BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49961144-230064BF-1B4E-4E2E-A21D-E6160ED032BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
89bba41442537c8a1886f84a442e74ac91c19231
P2860
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.